Journal Articles

Permanent URI for this collectionhttps://mro.massey.ac.nz/handle/10179/7915

Browse

Author: search.filters.author.Goddard A

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Two Point-of-Care Cardiac Troponin I Immunoassays Have Acceptable Analytical Performance for the Detection of Measurands of Cardiac Troponin I Cardiac Muscle Homogenates From Southern-Central Black Rhinoceros (Diceros bicornis minor) and Southern White Rhinoceros (Ceratotherium simum simum)
    (Wiley Periodicals LLC on behalf of American Society for Veterinary Clinical Pathology, 2025-06-04) Rautenbach Y; Meyer LCR; Goddard A; Buss PE; Hooijberg EH
    Background Skeletal and possible cardiac muscle damage has been reported in chemically immobilized and transported African rhinoceros during conservation-related activities. The extent of cardiac muscle injury in these rhinoceros is unknown due to a lack of validated cardiac troponin I (cTnI) assays. However, recently, five human cTnI assays were deemed suitable for analytical validation in African rhinoceros based on cTnI sequencing results. Objectives The first objective was to validate two cTnI immunoassay point-of-care analyzers (POCAs) in African rhinoceros and, secondly, to perform quality control (QC) validation for the POCAs. Methods Analytical validation of the Stratus CS Acute Care Troponin I cTnI immunoassay and Atellica VTLi high sensitivity cTnI (hs-cTnI) assay was performed using rhinoceros serum samples and species-specific cardiac muscle homogenate. Experiments included precision studies, reportable range, hemoglobin interference studies, recovery studies, and detection limit studies, with results assessed against prescribed total allowable error (TEa) performance goals. Commercial quality control material (QCM) data were used to calculate bias and imprecision for QC validation. Results Imprecision was acceptable (1.9%–10.3%) and met low cTnI concentration performance goals. Reportable ranges were similar to the manufacturer's specifications. High hemoglobin concentrations in white rhinoceros resulted in a positive bias in the Stratus CS. A simple 13s QC rule using two levels of QCM and a TEa of 70% could be used in both analyzers, except at very low cTnI concentrations in the Atellica VTLi. Conclusions Both cTnI POCAs are suitable for use in African rhinoceros, and analytical performance goals for low cTnI concentrations in hs-cTnI assays were met.
  • Thumbnail Image
    Item
    Conserving wildlife in a changing world: Understanding capture myopathy - A malignant outcome of stress during capture and translocation
    (Oxford University Press on behalf of The Society for Experimental Biology, 2019-07-05) Breed D; Meyer LCR; Steyl JCA; Goddard A; Burroughs R; Kohn TA; Fuller A
    The number of species that merit conservation interventions is increasing daily with ongoing habitat destruction, increased fragmentation and loss of population connectivity. Desertification and climate change reduce suitable conservation areas. Physiological stress is an inevitable part of the capture and translocation process of wild animals. Globally, capture myopathy - a malignant outcome of stress during capture operations - accounts for the highest number of deaths associated with wildlife translocation. These deaths may not only have considerable impacts on conservation efforts but also have direct and indirect financial implications. Such deaths usually are indicative of how well animal welfare was considered and addressed during a translocation exercise. Importantly, devastating consequences on the continued existence of threatened and endangered species succumbing to this known risk during capture and movement may result. Since first recorded in 1964 in Kenya, many cases of capture myopathy have been described, but the exact causes, pathophysiological mechanisms and treatment for this condition remain to be adequately studied and fully elucidated. Capture myopathy is a condition with marked morbidity and mortality that occur predominantly in wild animals around the globe. It arises from inflicted stress and physical exertion that would typically occur with prolonged or short intense pursuit, capture, restraint or transportation of wild animals. The condition carries a grave prognosis, and despite intensive extended and largely non-specific supportive treatment, the success rate is poor. Although not as common as in wildlife, domestic animals and humans are also affected by conditions with similar pathophysiology. This review aims to highlight the current state of knowledge related to the clinical and pathophysiological presentation, potential treatments, preventative measures and, importantly, the hypothetical causes and proposed pathomechanisms by comparing conditions found in domestic animals and humans. Future comparative strategies and research directions are proposed to help better understand the pathophysiology of capture myopathy.
  • Thumbnail Image
    Item
    Does cooling affect skeletal muscle glycogen replenishment after an acute bout of fear-induced exertional hyperthermia in blesbok (Damaliscus pygargus phillipsi)?
    (Elsevier Inc, 2025-11-01) Kohn TA; Martin M; van Boom KM; Donaldson B; Blackhurst DM; Fitte A; Burroughs R; Steyl JCA; Goddard A; Meyer LCR
    Rhabdomyolyses is a clinical sign of capture myopathy in wild animals and may be linked to glycogen metabolism. To study potential mechanisms, 26 wild blesbok were chased for 15 min and immobilised, whereafter 12 of these blesbok were doused with ice-water (n = 14 chased only group; n = 12 chased + cooled group). An additional 12 blesbok served as resting (not chased) uncooled controls. Vastus lateralis biopsies were obtained after immobilisation for biochemical analyses. Biopsies obtained at initial capture, 3- and 16-days post exercise were analysed for glycogen content. Blesbok muscles contained predominantly myosin heavy chain (MHC) IIA (∼50 ± 9 %), followed by IIX (32 ± 10 %) and MHC I (18 ± 5 %), with no difference between groups. Citrate synthase (mean: 87 ± 48), 3-hydroxyacetyl co A dehydrogenase (47 ± 17), lactate dehydrogenase (1567 ± 654), phosphorylase (162 ± 94), phosphofructokinase (250 ± 123) and creatine kinase (12,455 ± 6372) activities (in μmol/min/g prot) were not different between groups. Similarly, superoxide dismutase (7.9 ± 7 U/mg prot), catalase (8.8 ± 5.8 mmol/min/g prot), and overall antioxidant capacity (ORAC: 23055 ± 18,460 μmol/g prot) were not different between groups. Glycogen content was reduced in both chased groups and not replenished by day 3. Glycogen supercompensation was observed on day 16 in both chased groups (∼33 % higher than resting control group). The results confirm that blesbok have high muscle metabolic capacities, and that glycogen resynthesis is slow, which could lead to metabolite deficiency during prolonged chase events (>15 min).